Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAG| |GTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGT
End
121136038/120378462 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/6657094; hsa-mir-10b/Downstream/7045075;
Upstream sequence
CAGATGCACCTGCCAATACACAGCCCAGGACTTCTGCAGGAGAAGCGGAAATTGCATCCCTGCCTTCTGACAGCCAGCTCTCTGACTGGGGTAGGGGGTA
Downstream sequence
GGCTCTGGGTAACTGGAGGGGCAGGAGAAGGGCTCAGCACAGGCCAAAGGCTAGGGGAGAACATGGCTGGGTAGAAGTGGGGAGCAGCTAGGACGCTAGC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.